Myelination: do astrocytes play a role?

Astrocytes are the most abundant cell type in the adult central nervous system (CNS), and their functional diversity in response to injury is now being appreciated. Astrocytes have long been considered the main player in the inhibition of CNS repair via the formation of the gliotic scar, but now it is accepted that astrocyte can play an important role in CNS repair and remyelination. Interest in the relationship between astrocytes and myelination focused initially on attempts to understand how the development of plaques of astroglial scar tissue in multiple sclerosis was related to the failure of these lesions to remyelinate. It is now considered that this is an end stage pathological response to injury, and that normally astrocytes play important roles in supporting the development and maintenance of CNS myelin. This review will focus on how this new understanding may be exploited to develop new strategies to enhance remyelination in multiple sclerosis and other diseases.

[1]  Lan Zhang,et al.  Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses , 2012, Neuropharmacology.

[2]  T. Olsson,et al.  Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis , 2012, Brain : a journal of neurology.

[3]  B. Barres,et al.  Genomic Analysis of Reactive Astrogliosis , 2012, The Journal of Neuroscience.

[4]  M. Cambron,et al.  White-Matter Astrocytes, Axonal Energy Metabolism, and Axonal Degeneration in Multiple Sclerosis , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  C. ffrench-Constant,et al.  In vitro modeling of central nervous system myelination and remyelination , 2012, Glia.

[6]  C. Moore,et al.  An alternate perspective on the roles of TIMPs and MMPs in pathology. , 2012, The American journal of pathology.

[7]  D. Miljkovic,et al.  Astrocytes in the tempest of multiple sclerosis , 2011, FEBS letters.

[8]  Arne Klungland,et al.  Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood–brain water uptake and confers barrier function on perivascular astrocyte endfeet , 2011, Proceedings of the National Academy of Sciences.

[9]  J. McClure,et al.  Functional Duality of Astrocytes in Myelination , 2011, The Journal of Neuroscience.

[10]  H. Hartung,et al.  Enhancing remyelination in disease--can we wrap it up? , 2011, Brain : a journal of neurology.

[11]  D. Rowitch,et al.  Myelin regeneration: a recapitulation of development? , 2011, Annual review of neuroscience.

[12]  R. Frausto,et al.  Astrocytic Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Promotes Oligodendrocyte Differentiation and Enhances CNS Myelination , 2011, The Journal of Neuroscience.

[13]  S. Whittemore,et al.  Astrocytes from the Contused Spinal Cord Inhibit Oligodendrocyte Differentiation of Adult Oligodendrocyte Precursor Cells by Increasing the Expression of Bone Morphogenetic Proteins , 2011, The Journal of Neuroscience.

[14]  H. Hartung,et al.  The complex world of oligodendroglial differentiation inhibitors , 2011, Annals of neurology.

[15]  Jack P Antel,et al.  Cells of the oligodendroglial lineage, myelination, and remyelination. , 2011, Biochimica et biophysica acta.

[16]  C. Moore,et al.  How factors secreted from astrocytes impact myelin repair , 2011, Journal of neuroscience research.

[17]  M. Sofroniew,et al.  Reactive astrocytes as therapeutic targets for CNS disorders , 2010, Neurotherapeutics.

[18]  T. Kilpatrick,et al.  Brain-Derived Neurotrophic Factor Promotes Central Nervous System Myelination via a Direct Effect upon Oligodendrocytes , 2011, Neurosignals.

[19]  B. Emery.  Transcriptional and post-transcriptional control of CNS myelination , 2010, Current Opinion in Neurobiology.

[20]  E. Ling,et al.  Microglia‐Derived Macrophage Colony Stimulating Factor Promotes Generation of Proinflammatory Cytokines by Astrocytes in the Periventricular White Matter in the Hypoxic Neonatal Brain , 2010, Brain pathology.

[21]  J. Newcombe,et al.  Extracellular Matrix in Multiple Sclerosis Lesions: Fibrillar Collagens, Biglycan and Decorin are Upregulated and Associated with Infiltrating Immune Cells , 2010, Brain pathology.

[22]  V. Lennon,et al.  Neurological autoimmunity targeting aquaporin-4 , 2010, Neuroscience.

[23]  J. Sloane,et al.  Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2 , 2010, Proceedings of the National Academy of Sciences.

[24]  E. Gundelfinger,et al.  Contributions of astrocytes to synapse formation and maturation — Potential functions of the perisynaptic extracellular matrix , 2010, Brain Research Reviews.

[25]  G. McKhann,et al.  Alexander Disease Mutant Glial Fibrillary Acidic Protein Compromises Glutamate Transport in Astrocytes , 2010, Journal of neuropathology and experimental neurology.

[26]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[27]  M. Sofroniew.  Molecular dissection of reactive astrogliosis and glial scar formation , 2009, Trends in Neurosciences.

[28]  R. Miller,et al.  Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis , 2009, Experimental Neurology.

[29]  K. Nave,et al.  The role of CNS glia in preserving axon function , 2009, Current Opinion in Neurobiology.

[30]  B. Song,et al.  Reactive Astrocytes Form Scar-Like Perivascular Barriers to Leukocytes during Adaptive Immune Inflammation of the CNS , 2009, The Journal of Neuroscience.

[31]  J. Grinspan,et al.  Sending Mixed Signals: Bone Morphogenetic Protein in Myelination and Demyelination , 2009, Journal of neuropathology and experimental neurology.

[32]  E. Wawrousek,et al.  Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. , 2009, Human molecular genetics.

[33]  M. Vingron,et al.  Paracrine control of oligodendrocyte differentiation by SRF-directed neuronal gene expression , 2009, Nature Neuroscience.

[34]  Ben A. Barres,et al.  Distinct Stages of Myelination Regulated by γ-Secretase and Astrocytes in a Rapidly Myelinating CNS Coculture System , 2008, Neuron.

[35]  B. Barres.  The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease , 2008, Neuron.

[36]  C. Lucchinetti,et al.  Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2 , 2008, The Journal of experimental medicine.

[37]  A. Sorenson,et al.  Myelinated, synapsing cultures of murine spinal cord – validation as an in vitro model of the central nervous system , 2008, The European journal of neuroscience.

[38]  J. Chan,et al.  The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation , 2008, Proceedings of the National Academy of Sciences.

[39]  S. Miller,et al.  Astrocytes in multiple sclerosis: A product of their environment , 2008, Cellular and Molecular Life Sciences.

[40]  S. Barnett,et al.  Astrocytes, but not olfactory ensheathing cells or Schwann cells, promote myelination of CNS axons in vitro , 2008, Glia.

[41]  F. Paul,et al.  Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica , 2008, Nature Clinical Practice Neurology.

[42]  J. Salzer,et al.  Type III neuregulin‐1 promotes oligodendrocyte myelination , 2008, Glia.

[43]  Anna C. Williams,et al.  Astrocytes—Friends or foes in multiple sclerosis? , 2007, Glia.

[44]  J. Satoh,et al.  TROY and LINGO‐1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions , 2007, Neuropathology and applied neurobiology.

[45]  S. Kumar,et al.  Combination of Growth Factors Enhances Remyelination in a Cuprizone-induced Demyelination Mouse Model , 2007, Neurochemical Research.

[46]  C. Howe.  Coated Glass and Vicryl Microfibers as Artificial Axons , 2006, Cells Tissues Organs.

[47]  M. Höpfner,et al.  Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12 , 2006, Neuroreport.

[48]  N. Gutowski,et al.  Tenascin C induces a quiescent phenotype in cultured adult human astrocytes , 2005, Glia.

[49]  Mahendra S Rao,et al.  Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation , 2005, Nature Medicine.

[50]  M. Nilsson,et al.  Astrocyte activation and reactive gliosis , 2005, Glia.

[51]  D. Loy,et al.  Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes , 2005, Experimental Neurology.

[52]  E. Richfield,et al.  EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy , 2005, Nature Medicine.

[53]  D. Edwards,et al.  Key Metalloproteinases Are Expressed by Specific Cell Types in Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.

[54]  E. Shooter,et al.  NGF Controls Axonal Receptivity to Myelination by Schwann Cells or Oligodendrocytes , 2004, Neuron.

[55]  S. Levison,et al.  Pro‐regenerative properties of cytokine‐activated astrocytes , 2004, Journal of neurochemistry.

[56]  Ngan B. Doan,et al.  Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury , 2004, The Journal of Neuroscience.

[57]  Jerry Silver,et al.  Regeneration beyond the glial scar , 2004, Nature Reviews Neuroscience.

[58]  V. Neuhoff,et al.  Isolation and cultivation of mature oligodendroglial cells , 1984, Naturwissenschaften.

[59]  Xiao-Ming Xu,et al.  Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury , 2003, Experimental Neurology.

[60]  M. Levin,et al.  A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosis , 2003, Multiple sclerosis.

[61]  R. Fields,et al.  Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. , 2002, Neuron.

[62]  B. Stankoff,et al.  Ciliary Neurotrophic Factor (CNTF) Enhances Myelin Formation: A Novel Role for CNTF and CNTF-Related Molecules , 2002, The Journal of Neuroscience.

[63]  B. Barres,et al.  Control of synapse number by glia. , 2001, Science.

[64]  D. Rodriguez,et al.  Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease , 2001, Nature Genetics.

[65]  C. ffrench-Constant,et al.  Laminin-2/Integrin Interactions Enhance Myelin Membrane Formation by Oligodendrocytes , 1999, Molecular and Cellular Neuroscience.

[66]  S. Levison,et al.  Ciliary neurotrophic factor stimulates astroglial hypertrophy in vivo and in vitro. , 1998, Experimental neurology.

[67]  C. ffrench-Constant,et al.  Expression of αvβ3 and αvβ8 integrins during oligodendrocyte precursor differentiation in the presence and absence of axons , 1997, Glia.

[68]  S. K. Malhotra,et al.  Reactive astrocytes: cellular and molecular cues to biological function , 1997, Trends in Neurosciences.

[69]  D. Turner,et al.  Reactive astrocytes express the embryonic intermediate neurofilament nestin. , 1994, Neuroreport.

[70]  L. Eng,et al.  GFAP and Astrogliosis , 1994, Brain pathology.

[71]  M. Lazar,et al.  A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. , 1994, Development.

[72]  H. Thoenen,et al.  Ciliary neurotrophic factor. , 1994, Journal of neurobiology.

[73]  M. Eddleston,et al.  Molecular profile of reactive astrocytes—Implications for their role in neurologic disease , 1993, Neuroscience.

[74]  P. Bovolenta,et al.  Differential activation of microglia and astrocytes in aniso‐ and isomorphic gliotic tissue , 1993, Glia.

[75]  R. Franklin,et al.  Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord , 1991, Journal of neurocytology.

[76]  J. Goldman,et al.  Tracing glial cell lineages in the mammalian forebrain , 1991, Glia.

[77]  O. Bogler,et al.  Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[78]  A. Crang,et al.  The relationship between type-1 astrocytes, Schwann cells and oligodendrocytes following transplantation of glial cell cultures into demyelinating lesions in the adult rat spinal cord , 1989, Journal of neurocytology.

[79]  W. Richardson,et al.  Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture , 1988, Nature.

[80]  W. Richardson,et al.  A role for platelet-derived growth factor in normal gliogenesis in the central nervous system , 1988, Cell.

[81]  M. Waterfield,et al.  Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. , 1988, Nature.

[82]  S. Gammeltoft,et al.  Insulin‐like growth factor I in cultured rat astrocytes: expression of the gene, and receptor tyrosine kinase. , 1987, The EMBO journal.

[83]  P. Polak,et al.  Mature oligodendrocytes cultured in the absence of neurons recapitulate the ontogenic development of myelin membranes. , 1986, Developmental neuroscience.

[84]  S. Pfeiffer,et al.  Stimulation of oligodendrocytes by extracts from astrocyte‐enriched cultures , 1986, Journal of neuroscience research.

[85]  M. Raff,et al.  Reconstitution of a developmental clock in vitro: a critical role for astrocytes in the timing of oligodendrocyte differentiation , 1985, Cell.

[86]  M. Raff,et al.  Differentiation of a bipotential glial progenitor cell in single cell microculture , 1985, Nature.

[87]  M. Noble,et al.  Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. , 1984, The EMBO journal.

[88]  M. Raff,et al.  A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium , 1983, Nature.

[89]  E. Müller.  Pathologische Anatomie und Pathogenese , 1910 .